Should I stop treatment for Lymphoma and focus on quality of life

LymphomaMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Deciding About Lymphoma Treatment: An Important Conversation

This is one of the most personal decisions you'll face, and it deserves careful thought with your healthcare team. I can help you understand the framework doctors use for these conversations, but this decision is deeply individual and requires discussion with your oncology team who knows your complete medical situation.

How Doctors Think About This Decision

According to NCCN Guidelines for Lymphomas, treatment decisions depend on several key factors:

Your specific situation matters:

  • Type of lymphoma you have (aggressive vs. indolent/slow-growing)
  • Stage of disease (how far it has spread)
  • How your lymphoma is responding to current treatment
  • Your overall health and ability to tolerate treatment
  • Your personal values about quality of life vs. treatment intensity
  • Available treatment options remaining for your situation

Different lymphoma types have very different natural histories. For example, some indolent (slow-growing) lymphomas may progress slowly even without treatment, while aggressive lymphomas like DLBCL typically require active treatment to control symptoms and extend survival.

What "Quality of Life Focus" Can Mean

This doesn't necessarily mean stopping all treatment. It can include:

  • Switching to gentler treatment approaches that have fewer side effects
  • Palliative care (comfort-focused care) alongside active treatment
  • Adjusting treatment intensity based on your goals
  • Managing symptoms more aggressively while treating the cancer less intensively
  • Clinical trials exploring new approaches that might offer better quality of life

Critical Questions to Ask Your Oncology Team

  1. "What is my lymphoma type and stage, and what does that typically mean for progression without treatment?"

  2. "How is my lymphoma responding to current treatment? Are we seeing improvement?"

  3. "What are my remaining treatment options if I continue, and what would they involve?"

  4. "What would happen if I stopped treatment now? What symptoms might develop, and over what timeframe?"

  5. "Are there gentler treatment approaches or clinical trials that might better match my quality-of-life goals?"

  6. "Can we discuss palliative care alongside any treatment I choose?"

  7. "How will we monitor my health if I reduce or stop treatment, and what would trigger restarting?"

Important Context

According to NCCN Guidelines, treatment decisions for lymphoma are individualized. Your care team should be discussing:

  • Your specific prognosis (what to expect)
  • How treatment might extend survival or improve symptoms
  • Side effects you're experiencing
  • Your personal priorities and values

This is a conversation, not a one-time decision. Your priorities may change, and treatment plans can be adjusted as your situation evolves.

Next Steps

Consider:

  • Writing down your concerns about quality of life and current treatment side effects
  • Bringing a trusted person to your next appointment to help you listen and take notes
  • Being honest about how treatment is affecting your daily life
  • Asking about palliative care specialists who focus specifically on quality of life alongside medical treatment

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncologist knows your complete medical picture—your lymphoma type, stage, response to treatment, and overall health—which are essential to making this decision together.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: